Age-adjusted dementia deaths rates were stable between 2018 and 2019, then increased in 2020 and decreased slightly in 2022.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

There was an increase in dyslipidemia incidence during the COVID-19 pandemic compared with the prepandemic period.

The FDA has extended the review period for the BLA for NT-501 in the treatment of macular telangiectasia type 2.

Digital eye strain is more common in patients without presbyopia than in individuals with the refractive condition.

Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years.

Black and White patients with NAION have a similar pathogenesis, but Black patients with the disease may experience a delayed referral for care, due to its low prevalence in this population. Compared ...

A Prescription Drug User Fee Act date of April 2, 2025 has been assigned to the resubmitted application. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug ...

Combining patching with active amblyopia interventions, such as vision therapy or perceptual learning, improves visual outcomes.

The use of SGLT2 inhibitors was associated with a significantly reduced risk for dementia and PD in patients with type 2 diabetes.

In adolescents, adequate sleep is associated with a reduced risk for hypertension, according to a study published online Nov. 11 in the Journal of the American ...

Respiratory syncytial virus (RSV) is associated with a considerable burden of hospitalizations, intensive care unit (ICU) admissions, and in-hospital deaths among adults.